Marketed products

Brand name (active ingredient) Disease Area Approved and marketed Owner
Chenodeoxycholic acid Leadiant (chenodeoxycholic acid) Cerebrotendinous Xanthomatosis Approved in the EU Leadiant Biosciences Ltd.
Natulan (procarbazine) *Hodgkin lymphoma and brain cancers *Approved in the EU Leadiant Biosciences Ltd.

Updated June 2017
*List not exhaustive.

Important Note

For patients: if you wish to report an adverse event related to one of our products, please contact your healthcare provider. In addition, you can contact us on safety@leadiantbiosciences.com.

For healthcare professionals: if you wish to report an adverse event related to one of our products, please follow the current regulatory procedure in force in your country or contact us at safety@leadiantbiosciences.com.

If your residence is in the U.S. or Canada, please consult the North American website for details on safety reporting.